KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Thermo Fisher Scientific (TMO) Gross Profit (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Gross Profit readings, the most recent being $7.7 billion for Q1 2026.

  • On a quarterly basis, Gross Profit rose 6.98% to $7.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $32.2 billion, a 6.93% increase, with the full-year FY2025 number at $31.6 billion, up 4.69% from a year prior.
  • Gross Profit hit $7.7 billion in Q1 2026 for Thermo Fisher Scientific, down from $9.0 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $9.0 billion in Q4 2025 to a low of $7.1 billion in Q1 2024.
  • Median Gross Profit over the past 5 years was $7.5 billion (2023), compared with a mean of $7.7 billion.
  • The widest YoY moves for Gross Profit: up 25.89% in 2022, down 47.16% in 2022.
  • Thermo Fisher Scientific's Gross Profit stood at $7.8 billion in 2022, then fell by 7.92% to $7.2 billion in 2023, then increased by 10.86% to $7.9 billion in 2024, then grew by 13.3% to $9.0 billion in 2025, then decreased by 13.81% to $7.7 billion in 2026.
  • The last three reported values for Gross Profit were $7.7 billion (Q1 2026), $9.0 billion (Q4 2025), and $7.8 billion (Q3 2025) per Business Quant data.